Oorsprong van het eerstegraads netwerk van Premal Patel
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
60
| Public Company | Pharmaceuticals: Major | 60 |
Subsidiary | Biotechnology | 24 | |
Public Company | Biotechnology | 9 | |
Public Company | Biotechnology | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Premal Patel via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Administrative Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
SANA BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member Founder Founder Director/Board Member Founder Human Resources Officer | |
GRAIL LLC
GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Electronic Equipment/Instruments | Director/Board Member Chairman Founder Director/Board Member Chairman Chief Executive Officer | |
Yale University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Doctorate Degree | |
University of California, Los Angeles | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
CELGENE | Biotechnology | President Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Administrative Officer Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal General Counsel | |
Altos Labs, Inc.
Altos Labs, Inc. BiotechnologyHealth Technology Altos Labs is a biotechnology company that focuses on cellular rejuvenation programming to restore cell health and resilience. The company is based in Redwood City, CA. The company's goal is to reverse disease and transform medicine. Altos Labs was founded by Rick Klausner and Hans Edgar Bishop. The CEO is Hal V. Barron. | Biotechnology | Director/Board Member Chairman Chief Executive Officer Founder | |
The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
University of Pennsylvania | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
The Column Group LLC
The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Private Equity Investor Corporate Officer/Principal Private Equity Investor | |
eFFECTOR Therapeutics Operations, Inc.
eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Sonoma Biotherapeutics, Inc. provides research, development, and manufacturing capabilities in cell therapy and genetic engineering. The company was founded by Jeffrey A. Bluestone, Fred Ramsdell, Alexander Rudensky, and Qizhi Tang in 2019 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Biotechnology | Founder Director/Board Member Director/Board Member | |
SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director of Finance/CFO Director/Board Member | |
The Johns Hopkins University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
SANOFI | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
BICYCLE THERAPEUTICS PLC | Biotechnology | Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
The Wharton School of the University of Pennsylvania | College/University | Doctorate Degree Masters Business Admin Graduate Degree | |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
The Leonard N Stern School of Business | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
ILLUMINA, INC. | Biotechnology | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Altrubio, Inc.
Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | Internet Retail | Chairman Director/Board Member | |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Founder Private Equity Analyst | |
University of Connecticut | College/University | Undergraduate Degree Undergraduate Degree | |
ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
IKARIA, INC. | Biotechnology | Director/Board Member Director/Board Member | |
BELLEROPHON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Acepodia Biotechnologies, Ltd.
Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | Biotechnology | Founder Director/Board Member | |
PharmAkea, Inc.
PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Carmot Therapeutics, Inc.
Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Biotechnology | Chief Executive Officer Director/Board Member | |
National Resilience, Inc.
National Resilience, Inc. Miscellaneous Commercial ServicesCommercial Services National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
The University of Chicago | College/University | Doctorate Degree Doctorate Degree | |
BRAINSTORM CELL THERAPEUTICS INC. | Biotechnology | Public Communications Contact Chief Tech/Sci/R&D Officer |
Statistieken
Internationaal
Verenigde Staten | 45 |
Verenigd Koninkrijk | 3 |
China | 2 |
Zwitserland | 2 |
Frankrijk | 2 |
Sectoraal
Health Technology | 30 |
Consumer Services | 15 |
Commercial Services | 4 |
Finance | 3 |
Electronic Technology | 2 |
Operationeel
Director/Board Member | 495 |
Corporate Officer/Principal | 288 |
Independent Dir/Board Member | 152 |
Undergraduate Degree | 86 |
Chief Tech/Sci/R&D Officer | 86 |
Sterkste connecties
Insiders | |
---|---|
Robert Nelsen | 80 |
Anthony Evnin | 46 |
Maggie Wilderotter | 43 |
Thomas Daniel | 35 |
Ronald Blaylock | 33 |
Jon Root | 28 |
Jay Flatley | 27 |
Patrick Yang | 27 |
Howard H. Pien | 27 |
Richard Klausner | 27 |
Larry Lasky | 27 |
Christopher Ehrlich | 26 |
Hans Bishop | 24 |
John Smither | 20 |
Catherine Friedman | 20 |
- Beurs
- Insiders
- Premal Patel
- Bedrijfsconnecties